Substituted heterocyclic compounds as dopamine-reuptake inhibito

Details Substituted heterocyclic compounds as dopamine-reuptake inhibito Substituted heterocyclic compounds as dopamine-reuptake inhibito

1993-07-16

1996-09-10

Rotman, Alan L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

546125, C07D41304, A61K 3146

Patent

active

055546269

ABSTRACT:
The present invention discloses compounds of the formula ##STR1## any mixture thereof, or a pharmaceutically acceptable salt thereof; wherein R, R.sup.3, and R.sub.4 each have the meanings set forth in the specification.
The compounds possess valuable pharmaceutical properties as dopamine reuptake inhibitors.

REFERENCES:
patent: 5260314 (1993-11-01), Sauerberg et al.
F. Ivy Carroll et al., J. Chem. Soc., Chem. Commun., 44-46 (1993).
F. Ivy Carroll et al., Abstracts of 205th ACS meeting, Denver, Co., Mar. 28-Apr. 2, 1993, item 84 (Feb. 26, 1993).
R. L. Clarke et al., J. Med. Chem. 16(11), 1261-1267 (1973).
F. Ivy Carroll et al., J. Med. Chem. 34, 883-883 (1991).
Meltzer et al., J. Med. Chem. 36(7), 855-862 (1993).

Affiliated with

Also associated with

Rating

Substituted heterocyclic compounds as dopamine-reuptake inhibito does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted heterocyclic compounds as dopamine-reuptake inhibito, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted heterocyclic compounds as dopamine-reuptake inhibito will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1320739